Trial Outcomes & Findings for Effect of Steroid for the Postoperative Swelling After Orthognathic Surgery (NCT NCT01431014)

NCT ID: NCT01431014

Last Updated: 2014-03-21

Results Overview

Measure of facial swelling will be performed using 3-dimensional photogrammetry. The 3d photo acquisition is non-invasive without radiation concern. The images will be taken before and after surgery to measure and compare the degree of facial swelling. Side effects from the steroid use are expected to be low under normal clinical dosage, but will also be monitored. Symptoms of wound infection, psychosis, and prolonged wound healing will be studied. There should be no long term complication, since the steroid use is one single dose.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

56 participants

Primary outcome timeframe

1 year

Results posted on

2014-03-21

Participant Flow

Participant milestones

Participant milestones
Measure
Dexamethasone"High-dose"
15mg Dexamethasone"high-dose" : 15 mg
Dexamethasone"Low-dose"
5mg Dexamethasone"low-dose" : 5mg
Overall Study
STARTED
34
34
Overall Study
COMPLETED
31
25
Overall Study
NOT COMPLETED
3
9

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effect of Steroid for the Postoperative Swelling After Orthognathic Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Dexamethasone"High-dose"
n=31 Participants
15mg Dexamethasone"high-dose" : 15 mg
Dexamethasone"Low-dose"
n=25 Participants
5mg Dexamethasone"low-dose" : 5mg
Total
n=56 Participants
Total of all reporting groups
Age, Categorical
<=18 years
1 Participants
n=99 Participants
5 Participants
n=107 Participants
6 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
n=99 Participants
20 Participants
n=107 Participants
50 Participants
n=206 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Continuous
23.16 years
STANDARD_DEVIATION 4.19 • n=99 Participants
20.92 years
STANDARD_DEVIATION 4.79 • n=107 Participants
22.16 years
STANDARD_DEVIATION 4.6 • n=206 Participants
Sex: Female, Male
Female
15 Participants
n=99 Participants
13 Participants
n=107 Participants
28 Participants
n=206 Participants
Sex: Female, Male
Male
16 Participants
n=99 Participants
12 Participants
n=107 Participants
28 Participants
n=206 Participants
Region of Enrollment
Taiwan
31 participants
n=99 Participants
25 participants
n=107 Participants
56 participants
n=206 Participants

PRIMARY outcome

Timeframe: 1 year

Measure of facial swelling will be performed using 3-dimensional photogrammetry. The 3d photo acquisition is non-invasive without radiation concern. The images will be taken before and after surgery to measure and compare the degree of facial swelling. Side effects from the steroid use are expected to be low under normal clinical dosage, but will also be monitored. Symptoms of wound infection, psychosis, and prolonged wound healing will be studied. There should be no long term complication, since the steroid use is one single dose.

Outcome measures

Outcome measures
Measure
Dexamethasone"High-dose"
n=31 Participants
15mg Dexamethasone"high-dose" : 15 mg
Dexamethasone"Low-dose"
n=25 Participants
5mg Dexamethasone"low-dose" : 5 mg
Effect of Perioperative Steroid for the Postoperative Swelling After Orthognathic Surgery
36 hours postoperatively
167.06 ml
Standard Deviation 55.93
190.73 ml
Standard Deviation 78.74
Effect of Perioperative Steroid for the Postoperative Swelling After Orthognathic Surgery
1week postoperatively
61.39 ml
Standard Deviation 30.14
57.62 ml
Standard Deviation 36.13
Effect of Perioperative Steroid for the Postoperative Swelling After Orthognathic Surgery
1month postoperatively
29.85 ml
Standard Deviation 19.40
19.34 ml
Standard Deviation 16.56

Adverse Events

Dexamethasone"Low-dose"

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Dexamethasone"High-dose"

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Lun-Jou Lo, MD,Hye-Young Kim, MD

Chang Gung Memorial Hospital

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place